82 related articles for article (PubMed ID: 17625445)
1. Stool DNA analysis detects premorphological colorectal neoplasia: a case report.
Øgreid D; Hamre E
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):725-7. PubMed ID: 17625445
[TBL] [Abstract][Full Text] [Related]
2. Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
[TBL] [Abstract][Full Text] [Related]
3. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
4. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
6. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
[TBL] [Abstract][Full Text] [Related]
7. Fecal Genetic Mutations and Human DNA in Colorectal Cancer and Polyps Patients.
Lima J; Teixeira Y; Pimenta C; Felipe AV; Silva TD; Junior EEDL; Saad SS; Deak E; Murray H; Manoukian Forones N
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2929-2934. PubMed ID: 31653137
[TBL] [Abstract][Full Text] [Related]
8. Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
[TBL] [Abstract][Full Text] [Related]
9. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
11. Screening for colon cancer.
Heiken JP
Cancer Imaging; 2006 Oct; 6(Spec No A):S13-21. PubMed ID: 17114066
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer. Advances in stool DNA testing lead to improved colorectal cancer detection rates.
Patman G
Nat Rev Gastroenterol Hepatol; 2014 May; 11(5):269. PubMed ID: 24709816
[No Abstract] [Full Text] [Related]
13. Multitarget stool DNA testing for colorectal-cancer screening.
Souverijn JH
N Engl J Med; 2014 Jul; 371(2):187. PubMed ID: 25006740
[No Abstract] [Full Text] [Related]
14. Multitarget stool DNA testing for colorectal-cancer screening.
Lee JK; Terdiman JP; Corley DA
N Engl J Med; 2014 Jul; 371(2):186. PubMed ID: 25006739
[No Abstract] [Full Text] [Related]
15. Multitarget stool DNA testing for colorectal-cancer screening.
Senore C; Segnan N
N Engl J Med; 2014 Jul; 371(2):185-6. PubMed ID: 25006738
[No Abstract] [Full Text] [Related]
16. Multitarget stool DNA testing for colorectal-cancer screening.
Brenner H; Werner S; Chen H
N Engl J Med; 2014 Jul; 371(2):184-5. PubMed ID: 25006737
[No Abstract] [Full Text] [Related]
17. Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF; Ransohoff DF; Itzkowitz SH
N Engl J Med; 2014 Jul; 371(2):187-8. PubMed ID: 25006736
[No Abstract] [Full Text] [Related]
18. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
[TBL] [Abstract][Full Text] [Related]
19. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
[TBL] [Abstract][Full Text] [Related]
20. Stool DNA and colorectal-cancer screening.
Robertson DJ; Dominitz JA
N Engl J Med; 2014 Apr; 370(14):1350-1. PubMed ID: 24645801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
